At what level of elevated blood lipids should statin therapy be initiated?

Whether to initiate statin therapy for elevated blood lipid levels depends not solely on numerical values but requires a comprehensive assessment integrating lipid parameters with baseline cardiovascular risk. Statin treatment should be initiated in cases of isolated elevated low-density lipoprotein (LDL) cholesterol accompanied by underlying comorbidities—or in cases of severe hyperlipidemia. Recurrent dizziness, fatigue, and persistently elevated lipid levels warrant prompt medical evaluation.

Elevated LDL cholesterol is the primary indicator for assessing hyperlipidemia. In healthy individuals, pharmacologic intervention may be considered when lipid levels exceed the upper limit of normal and lifestyle modifications prove ineffective. For patients with concomitant hypertension, diabetes, or coronary artery disease, lipid control targets are stricter; even mild elevations may necessitate drug therapy. Statins modulate lipid metabolism, stabilize atherosclerotic plaques, and reduce the risk of vascular complications.

Severe hyperlipidemia accelerates atherosclerosis progression and increases the risk of myocardial infarction and ischemic stroke. After diagnosis of dyslipidemia, individuals with mild disease may first adopt dietary control and regular physical activity, followed by monitoring over several months. Those whose lipid levels fail to normalize should receive long-term, consistent statin therapy to maintain optimal lipid control and slow the progression of vascular damage.

Adopting a daily low-salt, low-fat diet; engaging in regular physical activity to metabolize excess lipids; maintaining a stable, healthy body weight; and undergoing periodic lipid monitoring are essential for sustaining long-term vascular metabolic health.